New Avenues in the Non-Operative management of patients with rectal cancer - PDF Version

13-15 October 2022  Montreal, Canada

Over the last two decades, the watch and wait approach initiated by Habr-Gama has attracted support among multidisciplinary care delivery teams and patients. There is presently a wide diversity of phase II/III strategies under investigation. This meeting aims to bring together main players exploring these different options with either chemotherapy, standard radiation therapy, targeted radiation therapy/surgery and to open a multidisciplinary discussion on means to better select tumours and patient population to achieve a more personalised therapeutic index. The meeting will update recent published trials, introduce new technological and innovative options, on-going translational research that will contribute to this field, and is an invitation for a multidisciplinary discussion and collaboration effort among world experts in the field.

Please join us for a challenging time. For more information and registration visit